![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
https://orcid.org/0000-0003-1879-6353
References
- Bates SM, Middeldorp S, Rodger M, James AH, Greer I. 2016. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. Journal of Thrombosis and Thrombolysis 41:92–128.
- Bozic Mijovski M. 2019. Advances in monitoring anticoagulant therapy. Adv Clin Chem 90:197–213.
- Eichler P, Budde U, Haas S, Kroll H, Loreth RM, Meyer O, et al. 1999. First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4/heparin ELISA. Thrombosis and Haemostasis 81:625–629.
- Greinacher A. 2015. Heparin-induced thrombocytopenia. The New England Journal of Medicine 373:1883–1884.
- Hellgren M, Mistafa O. 2019. Obstetric venous thromboembolism: a systematic review of dalteparin and pregnancy. Journal of Obstetrics and Gynaecology : The Journal of the Institute of Obstetrics and Gynaecology 39:439–450.
- Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S, Crowther M. 2012. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis. Chest 141:e495S–e530S.
- Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinach ERA. 2006. Evaluation of pretest clinical score (4 T’s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. Journal of Thrombosis and Haemostasis : JTH 4:759–765.
- Malicev E. 2020. The use of flow cytometry in the diagnosis of heparin-induced thrombocytopenia (HIT). Transfusion Medicine Reviews 34:34–41.
- Marcucci R, Berteotti M, Gori AM, Giusti B, Rogolino AA, Sticchi E, et al. 2021. Heparin induced thrombocytopenia: position paper from the Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus 19:14–23.
- Nilius H, Kaufmann J, Cuker A, Nagler M. 2021. Comparative effectiveness and safety of anticoagulants for the treatment of heparin-induced thrombocytopenia. American Journal of Hematology 96:805–815.
- Salter BS, Weiner MM, Trinh MA, Heller J, Evans AS, Adams DH, et al. 2016. Heparin-induced thrombocytopenia: a comprehensive clinical review. Journal of the American College of Cardiology 67:2519–2532.
- Thrombosis and embolism during pregnancy and the puerperium: acute management (green-top guideline no. 37b) 2015 [Online]. Royal College of Obstetricians and Gynaecologists. [cited 2022 Mar 15]. Available from: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg37b
- Writing Committee Members, Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, et al. 2021. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 77:e25–e197.